HIV and Malaria

Achan J, Gasasira AF, Aweeka F, Havlir D, Rosenthal PJ, Kamya, MR. Prophylaxis and treatment of Malaria in HIV infected populations. Read Article ...pdf

Gasasira, A, Kamya MR, Vora N, Achan J, Charlebois E, Ruel T, Kateera F, Meya D, Havlir D, Rosenthal PJ, Dorsey, G: Effect of trimethoprim-sulfamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance. (submitted to CID)

Kamya, MR, Gasasira AF, Achan J, Mebrahtu T, Ruel T, Kekitiinwa A, Charlebois ED, Rosenthal PJ, Havlir D, Dorsey G. Effects of trimethoprim-sulfamethoxazole prophylaxis and insecticide-treated bednets on the risk of malaria among HIV-infected Ugandan children. AIDS 2007, 21(15):2059-66 2007. Read Article ...pdf


Ssewanyana I, Elrefaei M, Dorsey G, Ruel T, Jones NG, Gasasira A, Kamya M, Nakiwala J, Achan J, Charlebois E, Havlir D, Cao H. Profile of T Cell Immune Responses in HIV Infected Children from Uganda. JID 2007:196 (1 December). Read Article ...pdf


Bebell LM, Gasasira AF, Kiggundu M, Dokomajilar C, Kamya MR, Charlebois ED, Havlir D, Rosenthal PJ, Dorsey G. HIV-1 infection in patients referred for malaria blood smears at government health clinics in Uganda. JAIDS 2007, 46(5):624-30.
Read Article ...
pdf


Anne F. Gasasira, Moses R. Kamya, Jane Achan, Tsedal Mebrahtu, Joan Kalyango, Theodore Ruel, Edwin Charlebois, Sarah G. Staedke, Adeodata Kekitiinwa, Philip Rosenthal, Diane Havlir and Grant Dorsey. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. CID, (July 2008 issue).
Read Article ...
pdf


Byakika-Kibwika P, Ddumba E, Kamya M. Effect of HIV-1 infection on malaria treatment outcome in Ugandan patients. African Health Sciences 2007 Jun;7(2):86-92. Read Article ...pdf


German P, Greenhouse B, Coates C, Dorsey G, Rosenthal PJ, Charlebois E, Lindegardh N, Havlir D, Aweeka FT. Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz. Clinical Infectious Diseases 2007;44(6):889-91. Read Article ...pdf


German P, Greenhouse B, Coates C, Dorsey G, Rosenthal P, Charlebois E, Lindegardh N, Havlir D, Aweeka F. Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz. Clin Infect Dis. 2007 Mar 15;44(6):889-91.
Read Article ...pdf


Gasasira A, Dorsey G, Kamya MR, Havlir D, Kiggundu M, Rosenthal PJ, Charlebois E. False positive HIV EIA test results in uncomplicated malaria. Journal of Clinical Microbiology 2006;3021-4. Read Article ...pdf


Moses R. Kamya, Anne F. Gasasira, Jane Achan, Tsedal Mebrahtu, Adeodata Kekitiinwa, Edwin D. Charlebois, Philip J. Rosenthal, Diane Havlir, Grant Dorsey. The effect of co-trimoxazole prophylaxis and insecticide-treated bednets on the risk of malaria among HIV infected Ugandan children. ASTMH 55th Annual Meeting, November 12-16, 2006, Scientific Session 37, HIV in the Tropics. Page 89: Read Article ...pdf


Malamba S, Mermin J, Reingold A, Lule J, Downing R, Ransom R, Kigozi A, Hunt BM, Hubbard A, Rosenthal PJ, Dorsey G. Effect of cotrimoxazole prophylaxis taken by HIV-infected persons on the selection of sulfadoxine-pyrimethamine resistant malaria parasites among HIV-uninfected family members. American Journal of Tropical Medicine and Hygiene 2006;75(3):375-380.
Read Article ...pdf


Kamya MR, Gasasira AF, Yeka A, Bakyaita N, Nsobya SL, Francis D, Rosenthal PJ, Dorsey G, Havlir D. Effect of HIV infection on malaria treatment outcome in Uganda: A population based study. Journal of Infectious Diseases 2006;193(1):9-15.
Read Article ...
pdf


Parikh S, Liu J, Sijwali P, Gut J, Goldberg DE, Rosenthal PJ. Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin. Antimicrob Agents Chemother. 2006; 50:2207-9,
Read Article ...pdf


Gasasira AF, Dorsey G, Kamya MR, Havlir D, Kiggundu M, Rosenthal PJ, Charlebois ED. False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J Clin Microbiol. 2006 Aug;44(8): 3021-4 Read Article ...pdf


Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ. Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors. Antimicrobial Agents and Chemotherapy 2005 Jul;49(7):2983-5. Read Article ...pdf


Kamya MR, Kigonya CN, McFarland W. HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children. AIDS 2001 Jun 15;15(9):1187-8. Read Article ...pdf